Search JIM Advanced Search

Journal of Chinese Integrative Medicine ›› 2007, Vol. 5 ›› Issue (1): 50-55.doi: 10.3736/jcim20070110

• Original Experimental Research • Previous Articles     Next Articles

Effects of Gymnadenia conopsea alcohol extract on collagen synthesis in rat lungs exposed to silica and its mechanism of antioxidative stress

Jun Wang, Jing-Bo Zeng, Xue-Feng Zhao, Qian Li, Shi-Xin Wang   

  1. Department of Scientific Research, Medical College of Chinese People's Armed Police Force, Tianjin 300162, China
  • Online:2007-01-31 Published:2007-01-21

Objective: To explore the effects of Gymnadenia conopsea alcohol extract (GcAE) on the collagen synthesis in rat lungs exposed to silica and the influence on antioxidase activities, level of lipid peroxidation (LPO).

Methods: One hundred and twenty rats were randomly divided into control group, silica group, and GcAE-treated group. Silicotic animal models were established by direct tracheal instillation of silica into rat lungs surgically. From the second day of model establishment, rats in GcAE-treated group were orally given GcAE [8 g/(kg·d) corresponding to raw herb]. At 7, 14, 21, 28 and 60 days after establishment of the animal model, eight rats in each group were sacrificed, and samples were collected. The malondialdehyde (MDA) content, superoxide dismutase (SOD) and glutathione peroxidase (GPx) activities in plasma were assayed by a spectrophotometer. Types Ⅰ and Ⅲ collagen were detected by Sirius red polarization and microscopy, and measuered by Image-Pro Plus Version 4.5 for Windows software.

Results: GcAE could reduce the lung/body weight ratio of rats exposed to silica, the synthesis of types ⅠandⅢcollagen of the lungs and the level of lipid peroxidation, increase the activities of SOD and GPx.

Conclusion: GcAE can ameliorate the silica-induced pulmonary fibrosis by increasing the activities of antioxidase and alleviating the damage of lipid peroxidation to the lungs.

Key words: silicosis, collagen, lipid peroxidation, pulmonary fibrosis

CLC Number: 

  • R563

Table 1

Effects of GcAE on lung/body weight ratio of rats exposed to silica at different time points (?$\bar{x}±S$m,g/g)"

Group n Lung/body weight ratio at different time points
7th day 14th day 21st day 28th day 60th day
Control 8 6.61±0.87 6.06±1.22 6.76±1.08 6.86±0.42 5.26±0.50
Silica 8 11.04±1.52** 9.28±2.70** 9.11±1.20** 11.98±2.93** 13.91±4.13**
GcAE-treated 8 8.60±0.59 6.99±1.18**△△ 7.25±1.46** 7.97±1.27** 9.75±1.58**

Figure 1

Results of HE staining for lungs of rats exposed to silica at different time points (HE staining, ×100)A: 7 d, control group; B: 7 d,silica group; C: 7 d,GcAE-treated group; D:14 d, control group; E: 14 d, silica group; F: 14 d, GcAE-treated group; G: 21 d, control group; H: 21 d, silica group; I: 21 d, GcAE-treated group; J: 28 d, control group; K: 28 d, silica group; L: 28 d, GcAE-treated group; M: 60 d, control group; N: 60 d, silica group; O: 60 d, GcAE-treated group."

Figure 2

Effects of GcAE on the synthesis of types Ⅰand Ⅲ collagen of lungs of rats exposed to silica at different time points (Sirius red staining, ×200)A: 7 d, control group; B: 7 d, silica group; C: 7 d, GcAE-treated group; D: 14 d, control group; E: 14 d, silica group; F: 14 d, GcAE-treated group; G: 21 d, control group; H: 21 d, silica group; I: 21 d, GcAE-treated group; J: 28 d, control group; K: 28 d, silica group; L: 28 d, GcAE-treated group; M: 60 d, control group; N: 60 d, silica group; O: 60 d, GcAE-treated group."

Table 2

Effects of GcAE on type Ⅰ collagen positive area percent of lung in rats exposed to silica at different time points ($\bar{x}±S$,%)"

Group n Type Ⅰ collagen positive area percentage of lung at different time points
7th day 14th day 21st day 28th day 60th day
Control 8 44.44±1.49 46.81±0.81 46.21±1.04 46.31±1.23 46.63±0.89
Silica 8 85.56±1.65** 86.32±1.29** 82.84±0.83** 107.58±0.84** 111.28±1.62**
GcAE-treated 8 65.35±1.39*△△ 66.40±1.52*△△ 72.67±1.68*△△ 84.51±0.59*△△ 86.88±0.69*△△

Table 3

Effects of GcAE on type Ⅲ collagen positive area percent of lung in rats exposed to silica at different time points ($\bar{x}±S$,%)"

Group n Type Ⅲ collagen positive area percentage of lung at different time points
7th day 14th day 21st day 28th day 60th day
Control 8 46.15±1.12 46.82±1.21 47.73±0.73 46.94±1.07 45.81±0.87
Silica 8 49.22±0.81* 64.40±0.91* 75.55±0.94* 50.31±0.88 47.78±0.78
GcAE-treated 8 48.20±1.09 51.98±1.03 63.11±1.16* 49.40±0.73 46.85±1.06

Table 4

Effects of GcAE on MDA content in plasma from rats exposed to silica at different time points ($\bar{x}±S$,mol/L)"

Group n MDA content in plasma at different time points
7th day 14th day 21st day 28th day 60th day
Control 8 3.50±0.75 3.57±0.57 4.19±1.40 3.34±0.85 3.76±0.74
Silica 8 6.43±0.85** 6.88±1.29** 6.98±1.24** 6.12±1.26** 5.82±1.16*
GcAE-treated 8 4.78±0.47*△△ 5.39±0.47* 5.48±1.35* 5.29±0.75* 4.35±1.15

Table 5

Effects of GcAE on SOD activity in plasma from rats exposed to silica at different time points ($\bar{x}±S$,kU/L)"

Group n SOD activity in plasma at different time points
7th day 14th day 21st day 28th day 60th day
Control 8 292.53±40.63 288.11±54.32 294.09±56.21 288.00±25.69 278.50±23.14
Silica 8 314.84±28.89 183.62±26.31** 219.41±40.39* 218.44±30.48** 226.50±47.86*
GcAE-treated 8 302.67±12.95 243.95±37.79△△ 293.38±49.99 277.74±29.16 243.36±41.39

Table 6

Effects of GcAE on GPx activity in plasma from rats exposed to silica at different time points ($\bar{x}±S$,U/L)"

Group n GPx activity in plasma at different time points
7th day 14th day 21st day 28th day 60th day
Control 8 2 266.67±341.61 2 018.07±240.72 2 214.01±171.66 2 237.08±207.82 2 196.64±249.05
Silica 8 2 489.50±191.97 1 015.34±221.43** 1 227.83±81.77** 1 814.90±345.15* 1 876.38±304.79
GcAE-treated 8 2 199.58±235.53 2 359.34±221.43△△ 2 538.66±189.47△△ 2 422.41±587.15 2 298.04±277.42
[1] Mossman BT, Churg A . Mechanisms in the pathogenesis of asbestosis and silicosis[J]. Am J Respir Crit Care Med, 1998,157(5 Pt 1):1666-1680
[2] Fubini B, Hubbard A . Reactive oxygen species(ROS) and reactive nitrogen species(RNS) generation by silica in inflammation and fibrosis[J]. Free Radic Biol Med, 2003,34(12):1507-1516
[3] 江苏新医学院主编. 中药大辞典(上册)(第1版)[M]. 上海: 上海科学技术出版社, 1986,( 第1版):436
Jiangsu New Medical College . Dictionary of Chinese Materia Medica(Vol 1)(1st ed)[M]. Shanghai: Shanghai Scientific and Technical Publishers, 1986,( 1st ed):436
[4] 刘晓雷, 孟勇英, 宋宏春 , 等. 蓉嘎口服液在抗衰老实验中几项生化指标的测定[J]. 中国民族医药杂志, 1997,3(suppl):170-172
Liu XL, Meng YY, Song LC , et al. Rongga Decoction in anti-aging: defermination of several biochemical indicators[J]. Zhongguo Ming Zu Yi Yao Za Zhi, 1997,3(suppl):170-172
[5] Matsuda H, Morikawa T, Xie H , et al. Antiallergic phenanthrenes and stilbenes from the tubers of Gymnadenia conopsea[J]. Planta Med, 2004,70(9):847-855
doi: 10.1055/s-2004-827234 pmid: 15386193
[6] Crisby M, Nordin-Fredriksson G, Shah PK , et al. Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques:implications for plaque stabilization[J]. Circulation, 2001,103(7):926-933
[7] 李帅, 王栋, 匡海学 , 等 .手掌参的化学成分研究[J].中草药, 2001, 3 2(1): 18, 38
Li S, Wang D, Kuang HX , et al.A study of chemical constituents in Gymnadenia conopsea[J].Zhong Cao Yao, 2001, 3 2(1): 18, 38
[8] Konecny R, Leonard S, Shi X , et al.Reactivity of free radicals on hydroxylated quartz surface and its implications for pathogenicity experimental and quantum mechanical study[J].J Environ Pathol Toxicol Oncol, 2001, 20 Suppl 1(): 119-132
[1] Ju-Yeon Park, Young-Won Kwon, Sun-Ah Kim, Sun-Dong Park, Chang-Hyun Kim, Jin-Hee Kim, Ju-Hee Lee. Polyherbal formula SC-E3 inhibits rheumatoid arthritis activity in a mouse model of type-II collagen-induced arthritis. Journal of Integrative Medicine, 2021, 19(3): 265-273.
[2] Na Zhi, Qian Mo, Shuo Yang, Yuan-xing Qin, Hao Chen, Zeng-guang Wu, Cai-hong Lan, Jun Zhang, Yin-long Li. Treatment of pulmonary fibrosis in one convalescent patient with corona virus disease 2019 by oral traditional Chinese medicine decoction: A case report. Journal of Integrative Medicine, 2021, 19(2): 185-190.
[3] Xue-qing Yu, Shu-guang Yang, Yang Xie, Jian-sheng Li. Traditional Chinese medicine in the treatment of idiopathic pulmonary fibrosis based on syndrome differentiation: Study protocol of exploratory trial. Journal of Integrative Medicine, 2020, 18(2): 163-168.
[4] Lucky Legbosi Nwidu, Yibala Ibor Oboma. Telfairia occidentalis (Cucurbitaceae) pulp extract mitigates rifampicin-isoniazid-induced hepatotoxicity in an in vivo rat model of oxidative stress. Journal of Integrative Medicine, 2019, 17(1): 46-56.
[5] Hoda Mojiri-Forushani, Ali Asghar Hemmati, Mohammad Amin Dehghani, Ali Reza Malayeri, Hossein Hassan Pour. Effects of herbal extracts and compounds and pharmacological agents on pulmonary fibrosis in animal models: A review. Journal of Integrative Medicine, 2017, 15(6): 433-441.
[6] Samuel Joshua Pragasam, Vachana Murunikara, Evan Prince Sabina, Mahaboobkhan Rasool. Antiperoxidative potential of p-coumaric acid, a common dietary phenol, in adjuvant-induced arthritis in rats. Journal of Chinese Integrative Medicine, 2012, 10(8): 932-938.
[7] Zhou Xian-mei, Zhao Yang, He Cui-cui, Li Jian-xin. Preventive effects of Citrus reticulata essential oil on bleomycin-induced pulmonary fibrosis in rats and the mechanism. Journal of Chinese Integrative Medicine, 2012, 10(2): 200-209.
[8] Tapas Kumar Sur, Biswajit Auddy, Dipankar Bhattacharyya. Effects of Indian herbal formulation Body Revival on human platelet aggregation and myocardial ischemia in rats. Journal of Chinese Integrative Medicine, 2011, 9(7): 746-751.
[9] Xiao-ning Wang, Qing Tao, Qin Feng, Jing-hua Peng, Ping Liu, Yi-yang Hu. Effects of Chinese herbal medicine Yiguanjian Decoction on collagen metabolism of hepatic tissues in rats with CCI4-induced liver fibrosis. Journal of Chinese Integrative Medicine, 2011, 9(6): 651-657.
[10] Hua-qiang Zhai, Shuo-feng Zhang, Ming-chao Gao, Yang Liu, Min Ou, Fan-yun Meng, Yong-yan Wang. Effects of Herba Ephedra Sinicae and Fructus Schisandrae Chinensis on pathology of rats with bleomycin A5-induced idiopathic pulmonary fibrosis. Journal of Chinese Integrative Medicine, 2011, 9(5): 553-557.
[11] Yan-yan Tao, Qing-lan Wang, Ji-li Yuan, Li Shen, Cheng-hai Liu. Effects of vitamin E on mercuric chloride-induced renal interstitial fibrosis in rats and the antioxidative mechanism. Journal of Chinese Integrative Medicine, 2011, 9(2): 201-208.
[12] Evan Prince Sabina, Samuel Joshua Pragasam, Suresh Kumar, Mahaboobkhan Rasool. 6-Gingerol, an active ingredient of ginger, protects acetaminophen-induced hepatotoxicity in mice. Journal of Chinese Integrative Medicine, 2011, 9(11): 1264-1269.
[13] Gollapalle L. Viswanatha, Hanumanthappa Shylaja, K. Sadashiva Sandeep Rao, Yathiraj Ashwini, V. Ramaiah Santhosh Kumar, C. Gangadharaiah Mohan, Venkate Gowda Sunil, M. Venkateshappa Sarvesh Kumar, Subbanna Rajesh. Amelioration of immobilization stress-induced biochemical and behavioral alterations and mitochondrial dysfunction by naringin in mice: Possible mechanism of nitric oxide modulation. Journal of Chinese Integrative Medicine, 2011, 9(11): 1254-1263.
[14] Ju-bao Li, Hong-yun Zhao, Yong-jian Zhao, Quan Zhou, Ning Li, Peng Xu, Qi Shi, Yong-jun Wang. Effects of Chinese herbal medicine Yiqi Huayu Bushen Recipe on expressions of aggrecan and type Ⅹ collagen mRNAs in cells from degenerated human intervertebral discs. Journal of Chinese Integrative Medicine, 2011, 9(10): 1138-1144.
[15] Tao Zhou , Xiu-chuan Yan, Qian Chen, Yan-yan Tao, Yi-yang Hu, Ping Liu, Cheng-hai Liu . Effects of Chinese herbal medicine Fuzheng Huayu recipe and its components against hepatocyte apoptosis in mice with hepatic injury. Journal of Chinese Integrative Medicine, 2011, 9(1): 57-63.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] Jin-rong Fu. Establishment of multivariate diagnosis and treatment system of modern gynecology of traditional Chinese medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 22-24
[2] Hao Li, Ming-jiang Yao, Wen-ming Zhao, Jie Guan, Lin-lin Cai, Ling Cui. A randomized, controlled, double-blind trial of Huannao Yicong capsule in senile patients with mild cognitive impairment. Journal of Chinese Integrative Medicine, 2008, 6(1): 25-31
[3] Zhi-chun Jin. Problems in establishing clinical guideline for integrated traditional Chinese and Western medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 5-8
[4] SUN Ming-yu, ZUO Jian, DUAN Ji-feng, HAN Jun, FAN Shi-ming, ZHANG Wei, ZHU Li-fang, YAO Ming-hui. Antitumor activities of kushen flavonoids in vivo and in vitro. Journal of Chinese Integrative Medicine, 2008, 6(1): 51-59
[5] Min Cheng, Qiong Feng, Shu-wen Qian, Hui Gao, Cui-qing Zhu. Preliminary assay of p-amyloid binding elements in heart-beneficial recipe. Journal of Chinese Integrative Medicine, 2008, 6(1): 68-72
[6] Ning-qun Wang, Liang-duo Jiang, Zong-xing Li. Research progress in asthma-related quality of life. Journal of Chinese Integrative Medicine, 2008, 6(1): 93-97
[7] Jing-yuan Mao, Chang-xiao Liu, Heng-he Wang, Guang-li Wei , Zhen-peng Zhang, Jie Xing, Wang Xian liang , Ying-fei Bi . Effects of Shenmai Injection on serum concentration and pharmacokinetics of digoxin in dogs with heart failure. Journal of Chinese Integrative Medicine, 2010, 8(11): 1070-1074
[8] Zhi-mei Wang, Bin Zhang. A study on translation of ellipses in Huangdi Neijing from perspective of hermeneutic theory. Journal of Chinese Integrative Medicine, 2010, 8(11): 1097-1100
[9] Gui Yu, Jie Wang. Thinking on building the network cardiovasology of Chinese medicine. Journal of Chinese Integrative Medicine, 2012, 10(11): 1206-1210
[10] Pedro Saganha João, Doenitz Christoph, Greten Tobias, Efferth Thomas, J. Greten Henry. Qigong therapy for physiotherapists suffering from burnout: a preliminary study. Journal of Chinese Integrative Medicine, 2012, 10(11): 1233-1239